PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention
(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the
Read More(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the
Read More(By Jakob Emerson for Becker’s Hospital Review) A bipartisan group of senators are once again pushing for new regulations around
Read More